High expression of RAD21 predicts poor survival in patients with operated non-small-cell lung cancer.

Zhu, Tao; Gao, Zhaojia; Yuan, Kai; Wang, Yong

Zhu, Tao; Gao, Zhaojia; Yuan, Kai; Wang, Yong.

Afiliação

Zhu T; Division of Thoracic Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
Gao Z; Division of Thoracic Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
Yuan K; Heart and Lung Disease Laboratory, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.
Wang Y; Division of Thoracic Surgery, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, Jiangsu Province, China.

Tumori ; : 300891620910805, 2020 Mar 17.

Article em En | MEDLINE | ID: mdl-32178590

Palavras-chave

RAD21; expression; non-small cell lung cancer; prognosis; tissue microarray

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Tumori Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google